|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact assessment of pesticide residues in fish of Ganga river around Kolkata in west bengal 显示文摘 | Aktar M W Paramasivam M Sengupta D | 2009 | Environimental Monitoring and Assessment2009，157，14： | 1 |
| 2 | Impact assessment of pesticide residues in fish of ganga river around kolkata in west bengal 显示文摘 | Aktar W Paramasivam M Senqupta I) | 2008 | Environimental Monitoring and Assessment2008，157，14： | 1 |
| 3 | 2012, Human capital heterogeneity and organizational performance analysis 显示文摘 | HALICI A AKTAR KSIMOGLU M | 2012 | Emerging Markets Journal2012，1，1： | 1 |
| 4 | Impact Assessment of Various Parameters Polluting Ganga Water in Kolkata Region~ A Study for Quality Eval- uation and Environmental Implieation显示文摘 | Purkait S Ganguly M Aktar M W | 2009 | Environ mental Monitoring and Assessment2009，155，14： | 1 |
| 5 | Effects of different media andorganic additives interaction on in vitro regeneration of Dendrobium orchid显示文摘 | Aktar S Nasiruddin K M Hossain K | 2008 | J Agric Rural Dev2008，6，12： | 1 |
| 6 | Degradation dynamics and persistence of Quinolphos and Methomyl in/on Okra (Ablemoschus esculentus) fruits and cropped soil显示文摘 | Aktar M W Sengupta D Chowdhury A | 2008 | Bull Environ Contam Toxicol2008，80，1： | 1 |
| 7 | The seismotectonics of the Marmara region (Turkey) : results from a microseismic experiment显示文摘 | Gurbuz C Aktar M Eyidogan H etal | 2000 | Tectonophysics2000，316，1： | 1 |
| 8 | Provocation of hypotension during head- up tilt testing in subjects with no history of syncope or pre - syncope显示文摘 | Natale A Aktar M Jazayeri M | 1995 | Circulation1995，92，： | 1 |
| 9 | Degradation dynamics and persistence of Quinolphos and Methomyl in/on okra (Ablemoschus esculentus) fruits and cropped soil 显示文摘 | Aktar M W Sengupta D Chowdhury A | 2008 | Bull Environ Contain Toxicol2008，80，1： | 1 |
| 10 | Role of H2 receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)is a global pandemic putting the population at a high risk of infection-related health hazards,mortality and a potential failure of proper medical therapies.Therefore,it is necessary to evaluate the potential use of the existing drugs that could be used as options for the medical management of COVID-19 patients.AIM To evaluate the role of the H_(2) receptor blocker“famotidine”in COVID-19 illness.METHODS This study was done on seriously ill COVID-19 patients admitted to the intensive care unit(ICU)from different institutes in Bangladesh.Patients were divided into famotidine treatment group“A”(famotidine 40 mg to 60 mg oral formulation every 8 h with other treatment as given),and control group“B”(treatment as given).National early warning score(NEWS)-2,and sequential organ failure assessment day-1 score was calculated to evaluate the outcome.Outcomes were evaluated by the time required for clinical improvement,characterized as duration required from enrollment to the achievement of NEWS-2 of≤2 maintained for 24 h;time to symptomatic recovery,defined as the duration in days(from randomization)required for the recovery of the COVID-19 symptoms;mortality rate;duration of ICU and hospital stay;total period of hospitalization;the rate of supplementary oxygen requirement;the computed tomography(CT)chest recovery(%),the time required for the viral clearance and“NEWS-2”on discharge.RESULTS A total of 208 patients were enrolled in this study with 104 patients in each group.The famotidine treatment group had comparatively better recovery of 75%and a low mortality of 25%than the control with a recovery of 70%and a mortality of 30%.Duration of clinical improvement(group A 9.53 d,group B 14.21 d);hospitalization period among the recovered patients(group A 13.04 d,group B 16.31 d),pulmonary improvement in chest CT(group A 21.7%,group B 13.2%),and the time for viral clearance(group A 20.7 d,group B 23.8 d)were found to be statistically significant P≤0.05.However,the Kaplan Meier survival test was not significant among the two study groups,P=0.989.CONCLUSION According to our study,treatment with famotidine achieved a better clinical outcome compared to the control group in severe COVID-19 illness,although no significant survival benefit was found. | Abu Taiub Mohammed Mohiuddin Chowdhury Aktar Kamal Md Kafil Uddin Abbas Md Rezaul Karim Md Ahsan Ali Shubhashis Talukder H M Hamidullah Mehedi Hamid Hassan Abul Hossain Shahin Yarui Li Shuixiang He | 2022 | World Journal of Clinical Cases2022，10，23： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员